COLUMVI

Indicated For

Diffuse Large B-Cell Lymphoma (DLBCL)

About This Medication

# Genentech Oncology Co-pay Assistance Program Patient Guide: How to Get COLUMVI (glofitamab-gxbm) at Low or No Cost COLUMVI (glofitamab-gxbm) is a prescription medicine used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or large B-cell lymphoma arising from follicular lymphoma (FL) after two or more lines of systemic therapy.[1] The **Genentech Oncology Co-pay Assistance Program** helps eligible patients with **commercial insurance** reduce out-of-pocket costs for COLUMVI, potentially paying as little as $0 for co-pays, co-insurance, or deductibles.[2][7] ## About COLUMVI and Why Assistance Matters **COLUMVI (glofitamab-gxbm)** is a bispecific CD20-directed CD3 T-cell engager administered via IV infusion in a healthcare setting, typically every week initially, then less frequently.[1] As an oncology treatment, it can be expensive, with costs often exceeding thousands per dose. High out-of-pocket expenses can lead to treatment delays or discontinuation. This program from **Genentech** bridges that gap for those who qualify, ensuring access to this life-saving therapy without financial hardship.[2][4] ## Who Qualifies? Eligibility focuses on insurance type and prescription details, **not income**—making it accessible to a broad range of commercially insured patients. - **Age**: 18 years or older, or have a caregiver/legally authorized representative.[5] - **Prescription**: Must be for an **FDA-approved indication** of a Genentech Oncology product like COLUMVI.[2][5] - **Insurance**: **Commercial (private/non-governmental) only**. Excludes government programs.[2][4] ### Insurance Requirements Table | Insurance Type | Eligible? | Details | |---------------|-----------|---------| | **Commercial/Private** | **Yes** | Primary requirement; helps with co-pays, co-insurance, deductibles.[2][7] | | **Medicare/Medicare Advantage** | **No** | Government program exclusion.[1] | | **Medicaid** | **No** | Not covered.[1] | | **Medigap** | **No** | Supplemental to Medicare; excluded.[1] | | **TRICARE/DoD/VA** | **No** | Military/government coverage ineligible.[1] | | **Uninsured** | **No** | Commercial insurance required; see Genentech Patient Foundation alternative.[6][8] | **No income thresholds** apply, but **benefit limits and eligibility criteria** exist—review full terms at application.[2] ## Step-by-Step Application Process The program offers **multiple application methods** for convenience.[1] 1. **Check Eligibility**: Confirm commercial insurance and FDA-approved COLUMVI prescription. Visit CopayAssistanceNow.com or call (888) 249-4918.[1][2] 2. **Gather Info**: Prescription details, insurance card, personal info. No extensive documents typically needed beyond basics.[1] 3. **Apply Online**: Go to https://www.columvi.com/financial-support/apply.html or CopayAssistanceNow.com. Enter RxBIN, PCN, group number, Member ID for card activation.[1][3][7] 4. **Apply by Phone**: Call **(888) 249-4918** for Genentech Oncology questions or **(855) MY-COPAY (855-692-6729)** 9am–8pm ET, M-F (excl. holidays).[1][2] 5. **At Pharmacy/Doctor**: Use program card at **participating pharmacies, physicians' offices, or hospitals**. Prescription processed normally; program covers eligible costs.[1][7] **Reauthorization required** periodically—program notifies when benefits near limit or renewal needed.[1] ## Timeline and Delivery - **Processing**: Often instant upon approval; use card immediately at fill.[7] - **Delivery**: Fills at **participating pharmacies, physicians' offices, or hospitals**—no home delivery specified.[1] - **Activation**: Online/phone approval quick; some report same-day use.[2][3] **Ongoing Use**: Present card each fill. Covers as little as **$0 per dose** until benefit cap reached.[7] ## If Denied or Ineligible: Alternatives - **Government Insurance**: Explore **Genentech Patient Foundation** for free medicine based on financial need (separate app: call (888) 941-3331).[6][8][10] - **Uninsured/Underinsured**: Patient Foundation groups include commercial high OOP, no insurance, or government with high costs.[8] - **Independent Foundations**: Genentech supports co-pay foundations—ask provider.[9] - **Other PAPs**: Check Needymeds.org or RxAssist.org for COLUMVI options. - **Appeal**: Contact program if denied; verify insurance details.[2] **No biosimilar alternatives** currently for glofitamab-gxbm.[1] ## Important Tips for Success - Verify insurance excludes government coverage. - Use only for FDA-approved uses. - Track benefits—reauthorize promptly. - Call for Spanish support or questions.[6] This guide empowers you to access COLUMVI affordably. Always consult your doctor. ## Disclaimer This is general info based on program details as of last update—not medical/financial advice. Eligibility/terms change; confirm via official channels. Genentech not liable for misuse. See full Terms & Conditions at CopayAssistanceNow.com.[2][3] (Word count: 912)

Program information last verified: March 30, 2026